ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
ONI has raised $75 million in series B funding to further its goal of bringing single-molecule microscopy to scientists. ONI was founded in 2016 as a spin-off from the University of Oxford. The company says it has sold more than 120 of its Nanoimagers, which it calls the world’s first desktop single-molecule imaging device. Another firm, Eikon Therapeutics, launched last year to discover drugs with superresolution microscopy technology, which was the subject of the 2014 Nobel Prize in Chemistry.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter